Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 6, 2013, Pages

  Huang, Janice V ^a,b   Lu, Li ^a,b   Ye, Shuyu ^a,b   Bergman, Bryan C ^b   Sparagna, Genevieve C ^a,c   Sarraf, Mohammad ^a,b   Reusch, Jane E B ^a,b   Greyson, Clifford R ^a,b   Schwartz, Gregory G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Akt; Cardiolipin; Contractility; Fatty acids; Heart; Ischemia; Metabolic syndrome; Reperfusion

Indexed keywords

GLUCOSE; INSULIN; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIET; DYSLIPIDEMIA; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ACYL COENZYME A; ANIMALS; BLOOD GLUCOSE; CARDIOLIPINS; CHOLESTEROL; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; GLUCOSE; HEART FUNCTION TESTS; INSULIN; MAP KINASE SIGNALING SYSTEM; METABOLIC SYNDROME X; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SWINE; SWINE, MINIATURE;

EID: 84878547540     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00535.2012     Document Type: Article

References (63)

1. Axelsen LN, Lademann JB, Petersen JS, Holstein-Rathlou NH, Ploug T, Prats C, Pedersen HD, Kjolbye AL. Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol 298: R1560-R1570, 2010.
2. Balschi JA, Hai JO, Wolkowicz PE, Straeter-Knowlen I, Evanochko WT, Caulfield JB, Bradley E, Ku DD, Pohost GM. 1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids. J Mol Cell Cardiol 29: 471-480, 1997.
3. Beauchamp E, Goenaga D, Le Bloc'h J, Catheline D, Legrand P, Rioux V. Myristic acid increases the activity of dihydroceramide 4-desaturase 1 through its N-terminal myristoylation. Biochimie 89: 1553-1561, 2007.
4. Bergman BC, Tsvetkova T, Lowes B, Wolfel EE. Myocardial glucose and lactate metabolism during rest and atrial pacing in humans. J Physiol 587: 2087-2099, 2009.
5. Bier J, Sharaf B, Gewirtz H. Origin of anterior interventricular vein blood in domestic swine. Am J Physiol Heart Circ Physiol 260: H1732-H1736, 1991.
6. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 83: 247-261, 2009.
7. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146: 5341-5349, 2005.
8. Cardenas G, Torres JC, Zamora J, Banos G. Isolated heart function during ischemia and reperfusion in sucrose-fed rats: effect of insulin infusion. Cardiovasc Pathol 14: 256-264, 2005.
9. Caterson ID, Astbury LD, Williams PF, Vanner MA, Cooney GJ, Turtle JR. The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance. Biochem J 243: 549-553, 1987.
10. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J Biol Chem 217: 383-393, 1955.
11. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292: C33-C44, 2007.
12. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Meta-bolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 7: 7-11, 2006.
13. Dennis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol 23: 1077-1086, 1991.
14. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 99: 578-588, 1999.
15. Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids 85: 219-225, 2011.
16. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
17. Fang CX, Dong F, Thomas DP, Ma H, He L, Ren J. Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol 295: H1206-H1215, 2008.
18. Ghosh S, Rodrigues B. Cardiac cell death in early diabetes and its modulation by dietary fatty acids. Biochim Biophys Acta 1761: 1148-1162, 2006.
19. Gonsolin D, Couturier K, Garait B, Rondel S, Novel-Chate V, Peltier S, Faure P, Gachon P, Boirie Y, Keriel C, Favier R, Pepe S, Demaison L, Leverve X. High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery. Mol Cell Biochem 295: 217-228, 2007.
20. Greim CA, Roewer N, Schulte am Esch J. Assessment of changes in left ventricular wall stress from the end-systolic pressure-area product. Br J Anaesth 75: 583-587, 1995.
21. Guth BD, Wisneski JA, Neese RA, White FC, Heusch G, Mazer CD, Gertz EW. Myocardial lactate release during ischemia in swine. Relation to regional blood flow. Circulation 81: 1948-1958, 1990.
22. Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12: 217-234, 2007.
23. Innis SM, Clandinin MT. Dynamic modulation of mitochondrial innermembrane lipids in rat heart by dietary fat. Biochem J 193: 155-167, 1981.
24. Joyeux-Faure M, Rossini E, Ribuot C, Faure P. Fructose-fed rat hearts are protected against ischemia-reperfusion injury. Exp Biol Med (Maywood) 231: 456-462, 2006.
25. Lajoie C, Beliveau L, Trudeau F, Lavoie N, Massicotte G, Gagnon S, Calderone A. The rapid onset of hyperglycaemia in ZDF rats was associated with a widespread alteration of metabolic proteins implicated in glucose metabolism in the heart. Can J Physiol Pharmacol 84: 1205-1213, 2006.
26. Lassaletta AD, Chu LM, Robich MP, Elmadhun NY, Feng J, Burgess TA, Laham RJ, Sturek M, Sellke FW. Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia. Basic Res Cardiol 107: 243, 2012.
27. Lee J, Xu Y, Lu L, Bergman B, Leitner JW, Greyson C, Draznin B, Schwartz GG. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity. Am J Physiol Heart Circ Physiol 298: H310-H319, 2010.
28. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 46: 277-283, 2005.
29. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postischemic heart function. Circulation 91: 2071-2079, 1995.
30. Lib M, Rodriguez-Mari A, Marusich MF, Capaldi RA. Immunocapture and microplate-based activity measurement of mammalian pyruvate dehydrogenase complex. Anal Biochem 314: 121-127, 2003.
31. Liedtke AJ, Nellis S, Neely JR. Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res 43: 652-661, 1978.
32. Maddaford TG, Russell JC, Pierce GN. Postischemic cardiac performance in the insulin-resistant JCR:LA-cp rat. Am J Physiol Heart Circ Physiol 273: H1187-H1192, 1997.
33. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277: 22896-22901, 2002.
34. Molaparast-Saless F, Liedtke AJ, Nellis SH. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. J Mol Cell Cardiol 19: 509-520, 1987.
35. Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Perret P, Ghezzi C, de LJ, Boucher F. Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol Cell Biochem 272: 9-17, 2005.
36. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132, 2010.
37. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U. S adults: NHANES III to NHANES 1999-2006. Diabetes Care 34: 216-219, 2011.
38. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del MF, Gwathmey JK, Grazette L, Hemmings BA, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115: 2128-2138, 2005.
39. Ouwens DM, Diamant M, Fodor M, Habets DD, Pelsers MM, El HM, Dang ZC, van den Brom CE, Vlasblom R, Rietdijk A, Boer C, Coort SL, Glatz JF, Luiken JJ. Cardiac contractile dysfunction in insulinresistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 50: 1938-1948, 2007.
40. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731-8739, 1977.
41. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 105: 2303-2308, 2002.
42. Reinhardt CP, Dalhberg S, Tries MA, Marcel R, Leppo JA. Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique. Am J Physiol Heart Circ Physiol 280: H108-H116, 2001.
43. Rocchini AP, Wilson RF, Marker P, Cervenka T. Metabolic and hemodynamic effects of a graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study. Hypertension 27: 354-359, 1996.
44. Russell RR, III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114: 495-503, 2004.
45. Saely CH, Aczel S, Marte T, Langer P, Hoefle G, Drexel H. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 90: 5698-5703, 2005.
46. Schwartz GG, Xu Y, Greyson C, Cohen J, Lu L. Low-dose inotropic stimulation during left ventricular ischaemia does not worsen post-ischaemic dysfunction. Cardiovasc Res 32: 1024-1037, 1996.
47. Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. Diabetes 51: 1110-1117, 2002.
48. Skyschally A, van CP, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104: 15-18, 2009.
49. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA, Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 48: 1559-1570, 2007.
50. Sparagna GC, Johnson CA, McCune SA, Moore RL, Murphy RC. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res 46: 1196-1204, 2005.
51. Sugden MC, Orfali KA, Holness MJ. The pyruvate dehydrogenase complex: nutrient control and the pathogenesis of insulin resistance. J Nutr 125: 1746S-1752S, 1995.
52. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: 42-72, 2006.
53. Taniguchi Y, Ooie T, Takahashi N, Shinohara T, Nakagawa M, Yonemochi H, Hara M, Yoshimatsu H, Saikawa T. Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulinresistant rat. Diabetes 55: 2371-2378, 2006.
54. Thim T, Bentzon JF, Kristiansen SB, Simonsen U, Andersen HL, Wassermann K, Falk E. Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci (Lond) 110: 665-671, 2006.
55. Triana JF, Li XY, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial "stunning". Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res 69: 731-747, 1991.
56. van d V, Glatz JF, Stam HC, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881-940, 1992.
57. van HG, Stromstad M, Rasmussen P, Jans O, Zaar M, Gam C, Quistorff B, Secher NH, Nielsen HB. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 29: 1121-1129, 2009.
58. Wang CC, Gunter J, Leitner JW, Lu L, Xu Y, Greyson C, Gianani R, Draznin B, Reusch JE, Schwartz GG. Early defects occur in PI3-kinase/ Akt signaling and vascular function in a novel porcine model of dietinduced obesity (Abstract). Diabetes 59, suppl 1: A66, 2010.
59. Wang P, Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286: E725-E736, 2004.
60. Wassink AM, van der GY, Olijhoek JK, Visseren FL. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 29: 213-223, 2008.
61. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 51: 93-102, 2008.
62. Xu Y, Lu L, Greyson C, Rizeq M, Nunley K, Wyatt B, Bristow MR, Long CS, Schwartz GG. The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 290: H1798-H1807, 2006.
63. Yatskar L, Holper E, Bansilal S, Schwartzbard A, Lombardero M, Ramanathan K, Feit F, Fisher E, Faxon D, Hochman JS, Farkouh ME. Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. Atherosclerosis 198: 389-395, 2008.